CHRISTOPHER HAAKON SCOTT
Pilots at Mt Alifan Dr, San Diego, CA
License number
California A4901599
Issued Date
Jul 2014
Expiration Date
Jul 2019
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
4835 Mt Alifan Dr, San Diego, CA 92111
Professional information
Adjunct Professor At University Of San Diego
Position:
Adjunct Professor at University of San Diego, Core Adjunct Professor at National University
Location:
Greater San Diego Area
Industry:
Research
Work:
University of San Diego
- San Diego since Aug 2011
-
Adjunct Professor
National University
- San Diego since Jan 2010
-
Core Adjunct Professor
Next2eden.net
- San Diego, CA Jan 2008 - Dec 2012
-
Founder & Editor
Anthology
2008 - 2012
-
patron
Advanced Biomedical Solutions, Inc.
Nov 2007 - Dec 2012
-
CEO
The Scripps Research Institute
Apr 2007 - Oct 2007
-
Technology Transfer Officer
UCSD Extension
2003 - 2006
-
Proteomics Course Coordinator
Biosite Diagonstics
Aug 2003 - Dec 2005
-
Research Scientist
Geneformatics, Inc.
Aug 2000 - Dec 2001
-
Staff scientist
Education:
The Scripps Research Institute 1993 - 1998
Ph.D., Protein Structural Biology University of Toronto 1989 - 1992
M.Sc., Medical Genetics University of Guelph 1983 - 1988
B.Sc., Human Biology
Ph.D., Protein Structural Biology University of Toronto 1989 - 1992
M.Sc., Medical Genetics University of Guelph 1983 - 1988
B.Sc., Human Biology
Skills:
Genetics, Proteomics, Molecular Biology, Teaching, Biochemistry, Cell Biology, Biotechnology, Lifesciences, Protein Chemistry, Biomarkers, Laboratory, Cell Culture, DNA sequencing, Genomics, PCR, Research, Western Blotting, Microscopy, Protein Expression, Science, Scientific Writing, qPCR, Fluorescence, Technology Transfer, Protein Purification, Flow Cytometry, DNA, Drug Discovery, Immunology, Biophysics, Chemistry, Bioinformatics, Computational Biology
Interests:
Interplay between conventional western medicine and wellness therapy, stamp collecting (Canadian mints), webpage design, digital music, and book writing
Honor & Awards:
• Individual NRSA NIH Fellowship 1 F32 HL10347-01 - (2000 - 2001)
• Outstanding Presentation, Keystone Symposium - (1996)
• Open College Award, University of Toronto - (1990)
• National Science Research Council undergraduate scholarship - (1985, 1986, 1988)
Dr. Christopher I Scott, Encinitas CA - MD (Doctor of Medicine)
Specialties:
Emergency Medicine
Address:
354 Santa Fe Dr, Encinitas 92024
(760) 633-7685 (Phone)
4077 5Th Ave, San Diego 92103
(619) 260-7000 (Phone)
HENRY MAYO NEWHALL MEMORIAL HOSPITAL
23845 Mcbean Pkwy, Valencia 91355
(661) 253-8400 (Phone), (661) 253-8879 (Fax)
(760) 633-7685 (Phone)
4077 5Th Ave, San Diego 92103
(619) 260-7000 (Phone)
HENRY MAYO NEWHALL MEMORIAL HOSPITAL
23845 Mcbean Pkwy, Valencia 91355
(661) 253-8400 (Phone), (661) 253-8879 (Fax)
Languages:
English
Education:
Medical School
George Washington University / School of Medicine And Health Sciences
Graduated: 2009
George Washington University / School of Medicine And Health Sciences
Graduated: 2009
Method For Inhibition Of Phospholamban Activity For The Treatment Of Cardiac Disease And Heart Failure
US Patent:
2009014, Jun 11, 2009
Filed:
Oct 23, 2008
Appl. No.:
12/257329
Inventors:
KENNETH CHIEN - LA JOLLA CA, US
WOLFGANG DILLMAN - LA JOLLA CA, US
SUSUMU MINAMISAWA - LA JOLLA CA, US
HUAPING HE - LA JOLLA CA, US
MASAHIKO HOSHIJIMA - LA JOLLA CA, US
MARKUS MEYER - LA JOLLA CA, US
CHRISTOPHER SCOTT - SAN DIEGO CA, US
YIBIN WANG - LA JOLLA CA, US
GREGG J. SILVERMAN - LA JOLLA CA, US
WOLFGANG DILLMAN - LA JOLLA CA, US
SUSUMU MINAMISAWA - LA JOLLA CA, US
HUAPING HE - LA JOLLA CA, US
MASAHIKO HOSHIJIMA - LA JOLLA CA, US
MARKUS MEYER - LA JOLLA CA, US
CHRISTOPHER SCOTT - SAN DIEGO CA, US
YIBIN WANG - LA JOLLA CA, US
GREGG J. SILVERMAN - LA JOLLA CA, US
International Classification:
A61K 31/7088, A61P 9/00
US Classification:
514 44
Abstract:
The present invention provides a method for the treatment of heart failure through the use of small peptide complexes and recombinant proteins which function to enhance contractility in failing hearts and reduce blood pressure in individuals with hypertension by inhibiting the interaction between phospholamban and sacroplasmic reticulum Ca ATPase (SERCA2a) within cardiomyocytes. In addition, a means is provided for the transport of such therapeutic agents into the cytoplasm and nucleus of cardiomyocytes.
Method For Inhibition Of Phospholamban Activity For The Treatment Of Cardiac Disease And Heart Failure
US Patent:
2004012, Jun 24, 2004
Filed:
Nov 10, 2003
Appl. No.:
10/705791
Inventors:
Kenneth Chien - La Jolla CA, US
Wolfgang Dillman - La Jolla CA, US
Susumu Minamisawa - La Jolla CA, US
Huaping He - La Jolla CA, US
Masahiko Hoshijima - La Jolla CA, US
Markus Meyer - La Jolla CA, US
Christopher Scott - San Diego CA, US
Yibin Wang - La Jolla CA, US
Gregg Silverman - La Jolla CA, US
Wolfgang Dillman - La Jolla CA, US
Susumu Minamisawa - La Jolla CA, US
Huaping He - La Jolla CA, US
Masahiko Hoshijima - La Jolla CA, US
Markus Meyer - La Jolla CA, US
Christopher Scott - San Diego CA, US
Yibin Wang - La Jolla CA, US
Gregg Silverman - La Jolla CA, US
International Classification:
A61K038/17, A61K048/00, A61K039/395
US Classification:
514/007000, 514/044000, 424/130100
Abstract:
The present invention provides a method for the treatment of heart failure through the use of small peptide complexes and recombinant proteins which function to enhance contractility in failing hearts and reduce blood pressure in individuals with hypertension by inhibiting the interaction between phospholamban and sarcoplasmic reticulum Ca ATPase (SERCA2a) within cardiomyocytes. In addition, a means is provided for the transport of such therapeutic agents into the cytoplasm and nucleus of cardiomyocytes.